ARTICLE | Clinical News
Mircera methoxy polyethylene glycol-epoetin beta regulatory update
July 30, 2012 7:00 AM UTC
Roche has rights to Tamiflu, a neuraminidase (NEU1; SIAL1) inhibitor, from Gilead Sciences Inc. (NASDAQ:GILD, Foster City, Calif.). Xeloda is an oral prodrug form of 5-fluorouracil (5-FU). Pegasys i...